resources

Predicting the Relative In Vivo performance of Nanoformed and Crystalline Bulk Piroxicam Solid Suspensions from In Vitro Flux Measurements

Predicting the Relative In Vivo performance of Nanoformed and Crystalline Bulk Piroxicam Solid Suspensions from In Vitro Flux Measurements

Poster

Preview - This content has been restricted to logged in users only.

In vivo absorption and human pharmacokinetics predicted from in vitro dissolution/permeability data using a Gastrointestinal Unified Theoretical.
Predicting the Relative In Vivo performance of Nanoformed and Crystalline Bulk Piroxicam Solid Suspensions from In Vitro Flux Measurements

Poster

The data presented in this poster presented at the 2023 AAPS PharmSci 360 illustrates the applicability of in vitroflux assays in conjunction with predictive modelling software to predict the relative in vivoperformanceof formulations containing nanoformed Piroxicam.

Previous post